Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Hematol Oncol. 2021 Jun;39(Suppl 1):15–23. doi: 10.1002/hon.2857

Table 2.

Proposed Revised Classification of Histiocytocytic Disorders

L Group LCH
Intermediate-cell histiocytosis (ICH)
Erdheim-Chester disease (ECD)
Mixed LCH/ECD
C Group Cutaneous non-LCH
-Xanthomatous granuloma (XG) family: includes JXG
-Non-XG family: includes cutaneous RDD
Cutaneous non-LCH with major systemic component
-XG family: xanthoma disseminatum
-Non-XG: multicentric reticulohistiocytosis
R Group Familial RDD
Sporadic RDD
-Classic RDD
-Extranodal RDD
-RDD with neoplasia or immune disease
-Unclassified
M Group Primary malignant histiocytosis
Secondary malignant histiocytosis
H Group Primary HLH
Secondary HLH (non-Mendelian)
HLH of unknown/uncertain origin

LCH, Langerhans cell histiocytosis; ECD, Erdheim-Chester disease; JXG, juvenile xanthogranuloma; RDD, Rosai-Dorfman disease; HLH, hemophagocytic lymphohistiocytosis. Adapted from2